ESIRA, a novel framework integrating efficacy and safety for evaluating first-line treatments in advanced hepatocellular carcinoma

Science China Life Sciences 2026

View at publisher
Authors: Hai-Long Li, Hui Zhou, Yi-Yang Zhang, Jin-Ting Lai, Zhen-Zhong Zhou, Jing-Yi Huang, Song-Bin Guo, Yu Fei Wang, Wei-Juan Huang, Xiao-Peng Tian
DOI: 10.1007/s11427-025-3093-8
Cited by: 1
References: 36

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Ferroptosis and cancer prognosis Statistical Methods in Clinical Trials

Publication details

Journal / source
Science China Life Sciences
Publisher
Springer Science and Business Media LLC
Volume
69
Issue
3
Pages
912–920
Publication date
27 January 2026
Language
EN